Main > > >NEPHROLOGY.

---

Apheresis Machine. (Stand Alone Pump).
Uses: Continuous Renal Replacement Therapy. Therapeutic Plasma Exchange.
USA 510(K) Clearance Date: 2017. 12.18.
(*) Company; Patent Assignee & Web-Site
Available on Request.
UpDate: 2017. 12.19.




Atypical Hemolytic–Uremic Syndrome.
Treat.: RavulizuMAb Inj.
EU CE Mark Date : 2020. 06.29.
JP Approval Date: 2020. 09.25.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2021. 03.15.




Chronic Kidney Disease (CKD). HemoDia-
lysis. endoAVF System.
Creation of Arterio Venous Fistula (AVF)
using Ulnar Artery & Ulnar Vein with
minimum Artery & Vein Diameters of 2.0
mm & < 2.0 mm separation between Artery
& Vein at Fistula Creation Site.
EU Approval Date : 2017. 09.27.
USA Approval Date: 2018. 06.22.
(*) Companies; Patents; TradeMark &
Web-Sites Available on Request.
UpDate: 2018. 07.17.




Chronic Kidney Disease (CKD). Not On
Dialysis. HyperPhosphatemia. Treat.:
Bixalomer Granules.
JP Approval Date: 2016. 09.21.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 12.04.




Chronic Kidney Disease (CKD). Not On Dialysis. Iron Deficiency Anemia in Adult Patients. TREAT.: Ferric Citrate.
JP Approval Date: 2021. 03.24.
USA Approval Date: 2017. 11.07.
(*) Company; Patents; TradeMarks & Web-
Site Available on Request.
UpDate: 2021. 03.28.




Chronic Kidney Disease (CKD). Not on
Dialysis & On Dialysis. Treat.: VadaDus-
tat.
JP Approval Date: 2020. 06.29.
JP Launch Date: 2020. 08.26.
(*) Companies & Patents Available on
Request.
UpDate: 2021. 03.12.




Chronic Kidney Disease (CKD). On
Dialysis. Anemia. Treat.: RoxaDustat
Oral.
CN Approval Date: 2018. 12.17.
JP Approval Date: 2020. 11.27. (Not On
Dialysis)
JP Launch Year: 2019.
(*) Companies; Patents; TradeMark &
Web-Site Available on Request
UpDate: 2021. 03.30.




Chronic Kidney Disease (CKD). On
Dialysis. HyperPhosphatemia. Treat.:
Bixalomer Granules.
JP Approval Date: 2012. 06.26.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 12.04.




Chronic Kidney Disease (CKD). On Dialysis. HyperPhosphatemia. Treat.: Ferric Citrate.
EU Approval Date : ?
JP Approval Date : ?
USA Approval Date: 2014. 09.05.
USA Launch Date : 2014. 12.22.
(*) Company; Patents; TradeMarks & Web-
Site Available on Request.
UpDate: 2018. 03.14.




Chronic Kidney Disease (CKD). On
Dialysis. HyperPhosphatemia. Treat.:
Sevelamer Carbonate Oral Suspension.
Generic.
USA Launch Date: 2018. 12.27.
(*) Company: Dr. Reddy s Labs.
UpDate: 2018. 12.28.




Chronic Kidney Disease (CKD). On
Dialysis. HyperPhosphatemia. Treat.:
Sevelamer Carbonate Tablets. Brand.
EU Approval Date : 2009. 06.10.
USA Approval Date: 2007. 10.22.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 12.04.




Chronic Kidney Disease (CKD). On
Dialysis. HyperPhosphatemia. Treat.:
Sevelamer Carbonate Tablets. Generic.
USA Launch Date: 2017. 09.29.
(*) Company: Dr. Reddy Laboratories.
UpDate: 2018. 12.04.




Chronic Kidney Disease (CKD). On
Dialysis. HyperPhosphatemia. Treat.:
Sevelamer Carbonate Tablets. Generic.
USA Approval & Launch Date: 2017. 10.23.
(*) Company: Impax.
UpDate: 2018. 12.04.




HemoDialysis (HD). Catheter. AntiMi-
crobial Barrier Caps.
EU CE Mark Date: 2019. 04.03.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 10.28.




HyperKalemia. TREAT.: Patiromer Sorbitex Ca.
Critical Care Medicine.
Fluorinated Polymer.
CH Approval Date: 2018. 01.04.
EU Approval Date: 2017. 07.21.
USA Approval Date: 2015. 10.21.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 01.05.




Lupus Nephritis. Treat.: Voclosporin
Capsules.
USA Approval Date: 2021. 01.22.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2021. 04.04.




Peritoneal Dialysis (PD). Connector.
DisInfection UV System.
USA Approval Date: 2016. 01.26.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 10.27.




>NEPHROLOGY.'s products
This section has no products